Hemophilia

Hemophilia: A Rare Blood Clotting Disorder

An uncommon hereditary condition known as haemophilia causes improper blood clotting by a shortage of clotting components. This phenomenon causes extended bleeding—even from minor injuries—as well as a higher risk of internal bleeding, a potentially fatal condition.
Haemophilia A, brought on by a shortfall of clotting factor VIII, and Haemophilia B, brought on by a shortfall of factor IX, are the two primary forms of haemophilia. The degree of the condition ranges; severe cases may cause pain, oedema, and possible joint injury by means of spontaneous bleeding in muscles and joints.
Blood tests measuring clotting factor levels diagnose haemophilia. Families with a history of the inherited ailment usually advise genetic testing.
Treatment typically involves replacing the missing clotting factor by injecting it into the bloodstream to prevent excessive bleeding. Severe cases call for consistent preventative therapy. To raise patient outcomes, newer treatments like non-factor replacement medications and gene therapy are under development.
Those with haemophilia should stay away from high-risk sports, maintain good joint health, and get the right medical help if they show any internal bleeding symptoms.